Executive Order 13879, signed on July 10, 2019, directed the Department of Health and Human Services to restructure federal policy governing kidney disease treatment and organ transplantation. The order required HHS to modify Medicare reimbursement rates for dialysis providers and establish new standards for organ procurement and allocation. Specifically, the administration sought to expand home dialysis options as an alternative to in-center treatment and streamline the process by which patients move from dialysis to kidney transplantation, nominally to increase access and reduce costs for the federal government.

The direct beneficiaries were intended to be Americans with end-stage kidney disease, a population numbering roughly 750,000 people, with approximately 500,000 receiving dialysis treatment. Changes to Medicare payment structures, however, created ripple effects throughout the dialysis care industry. Dialysis providers faced altered revenue models, potentially affecting staffing and service capacity at treatment centers. Simultaneously, modifications to organ allocation standards shifted how organs were distributed, affecting transplant waitlist priorities and access patterns across different patient demographics.

This action reflected a broader pattern within the Trump administration of restructuring federal health programs through executive authority rather than legislative channels. Similar to the Title X reorientation away from birth control access and the vaccine recommendation changes, this order implemented significant healthcare policy shifts without congressional authorization. The administration positioned these moves as efficiency measures while effectively redistributing resources and altering how vulnerable populations accessed medical services.

The legal status of the executive order remained intact through the remainder of the Trump presidency, though specific implementation directives faced scrutiny regarding their adherence to existing Medicare statute. The order's expansion of home dialysis aligned with bipartisan interest in patient choice, yet the payment modifications were contested by dialysis providers concerned about operational viability. Unlike some contemporaneous health actions that faced immediate judicial stays, this order largely proceeded through administrative channels without definitive court intervention blocking implementation.